Dr. Stevens is an Assistant Professor of Pathology. He serves as the Medical Director for the Clinical Mycobacteriology and Mycology Laboratories within the Division of Clinical Microbiology.
Education & Training
BS – The Ohio State University, 2011
MD – The University of Toledo, 2015
Residency – Clinical Pathology, University of Pittsburgh Medical Center, 2019
Fellowship – Medical Microbiology, Stanford University, 2020
Representative Publications
- de Hoog, S., et al. (including Stevens BA). A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC. J Clin Microbiol. 2023 Oct 26:e0087323 PMID: 37882528
- Pepper M, Wiredja D, Patel P, Stevens BA, Pinky BA, Shi R. A spurious positive result on the Abbott Architect 4th generation HIV Ag/Ab combo assay in a low-risk patient. Clin Chim Acta. 2022 Jun 1;531:386-388 PMID 35568208
- Elkhadrawi M, Stevens BA, Wheeler BJ, Akcakaya M, Wheeler S. Machine learning classification of false-positive human immunodeficiency virus screening results. J Pathol Inform 2021;12:46 PMID 34934521
- Wang H, Hogan CA, Verghese M, Solis D, Sibai M, Huang C, Röltgen K, Stevens BA, Yamamoto F, Sahoo MK, Zehnder J, Boyd SD, Pinsky BA. SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19. Clin Chem. 2021 Oct 4:hvab216. PMID: 34605900
- Ferguson J, Mooney K, Saleem A, Stevens BA, Pinsky BA, Centkowski S, Zaba LC, Ho DY. Cutaneous cytomegalovirus - A case of disseminated cytomegalovirus presenting with extensive ulcerative skin lesions in a renal transplant recipient. Transpl Infect Dis. 2021 Aug;23(4):e13582 PMID: 33533137.
- Wirz OF, Röltgen K, Stevens BA, Pandey S, Sahoo MK, Tolentino L, Verghese M, Nguyen K, Hunter M, Snow TT, Singh AR, Blish CA, Cochran JR, Zehnder JL, Nadeau KC, Pinsky BA, Pham TD, Boyd SD. Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion. Front Immunol. 2021 Sep 14;12:739037 PMID: 34594341
- Lawrence L, Stevens BA, Sahoo MK, Huang C, Yamamoto F, Röltgen K, Wirz O, Zehnder J, Shi RZ, Boyd SD, Schoolnik G, Pinsky BA, Hogan CA. Plasma as an alternative COVID-19 diagnostic specimen in a hospitalized patient negative for SARS-CoV-2 by nasopharyngeal swab. Diagn Microbiol Infect Dis. 2021 Jul;100(3):115365 PMID: 33865070
- Sibai M, Solis D, Röltgen K, Stevens BA, Mfuh KO, Sahoo MK, Shi RZ, Zehnder J, Boyd SD, Pinsky BA. Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay. J Clin Virol. 2021 Jun;139:104818 PMID: 33932848
- Stevens BA, Hogan CA, Mfuh KO, Khan G, Sahoo MK, Huang C, Garamani N, Zehnder J, Kurzer J, Pinsky BA. Combined SARS-CoV-2 nucleic acid amplification testing and respiratory virus panel RT-PCR on the Hologic Panther Fusion system. J Clin Virol. 2021 May;138:104792. doi: 10.1016/j.jcv.2021.104792. Epub 2021 Mar 10. PMID: 33770659; PMCID: PMC7944800.
- Röltgen K*, Powell AE*, Wirz OF*, Stevens BA*, Hogan CA, Najeeb J, Hunter M, Wang H, Sahoo MK, Huang C, Yamamoto F, Manohar M, Manalac J, Otrelo-Cardoso AR, Pham TD, Rustagi A, Rogers AJ, Shah NH, Blish CA, Cochran JR, Jardetzky TS, Zehnder JL, Wang TT, Narasimhan B, Gombar S, Tibshirani R, Nadeau KC, Kim PS, Pinsky BA, Boyd SD. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Sci Immunol. 2020 Dec 7;5(54):eabe0240. PMID: 33288645